Detalhe da pesquisa
1.
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
Cell;
184(11): 2955-2972.e25, 2021 05 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34019795
2.
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Cell;
182(4): 812-827.e19, 2020 08 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32697968
3.
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.
Cell;
163(7): 1702-15, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26687358
4.
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.
Immunity;
51(4): 724-734.e4, 2019 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31586542
5.
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.
Immunity;
46(6): 1073-1088.e6, 2017 06 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28636956
6.
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.
PLoS Pathog;
18(6): e1010574, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35709309
7.
A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection.
PLoS Pathog;
18(6): e1010507, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35714165
8.
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
PLoS Pathog;
18(11): e1010945, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36395347
9.
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
Proc Natl Acad Sci U S A;
118(3)2021 01 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33431684
10.
Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
J Virol;
96(11): e0023122, 2022 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35536018
11.
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
J Virol;
96(1): e0155221, 2022 01 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34669426
12.
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
PLoS Pathog;
17(6): e1009624, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34086838
13.
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
PLoS Pathog;
17(8): e1009736, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34432859
14.
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone.
J Immunol;
206(6): 1266-1283, 2021 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33536254
15.
Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus.
J Infect Dis;
225(10): 1731-1740, 2022 05 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34962990
16.
A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.
J Virol;
95(15): e0235020, 2021 07 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33980592
17.
The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
J Virol;
95(7)2021 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33441339
18.
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
PLoS Pathog;
16(4): e1008531, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32343743
19.
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates.
PLoS Pathog;
16(8): e1008753, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32866207
20.
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
PLoS Pathog;
16(3): e1008377, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32163525